NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity RFA-DA-25-035 from the NIH Guide for Grants and Contracts. This NOFO seeks applications from the SUD and MHD research communities that coordinate efforts to characterize the effects of neuromodulation on brain circuits and behaviors relevant to both SUD and MHD. To accomplish this goal, studies would specify inclusion/exclusion criteria to capture variance in both SUD and MHD symptoms. Further, studies would include measures of engagement of circuit-level targets in response to neuromodulation and dimensional measures of cognition and behavior relevant to both SUD and MHD. This research approach uses circuit dynamics to understand neurobehavioral function and to develop ecologically valid and descriptive models of the shared and discrete dysfunction across these conditions.
Notice NOT-EY-24-003 from the NIH Guide for Grants and Contracts
Notice NOT-HD-24-017 from the NIH Guide for Grants and Contracts
Notice NOT-HL-24-013 from the NIH Guide for Grants and Contracts
Notice NOT-HL-24-011 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-105 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-095 from the NIH Guide for Grants and Contracts
Notice NOT-CA-24-039 from the NIH Guide for Grants and Contracts
Notice NOT-AT-24-040 from the NIH Guide for Grants and Contracts
Notice NOT-HG-24-031 from the NIH Guide for Grants and Contracts
Notice NOT-HD-24-018 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-24-203 from the NIH Guide for Grants and Contracts. This NOFO will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to incorporate AD/ADRD risk factors, pathologies, or relevant comorbidities. To this end, proposals can focus on one or more of the following: - Mechanistic studies that address how COVID-19 impacts CNS pathology and cognitive outcomes when AD/ADRD pathology is already present (for example, in a model of AD/ADRD). - Mechanistic studies that address how COVID-19 accelerates AD/ADRD pathology and cognitive deficits in a prodromal model (early phase, pre-symptomatic). - Mechanistic studies that address how COVID-19 predisposes for AD/ADRD and/or interacts with relevant comorbid conditions and risk factors (cellular mechanisms that could potentially increase the risk for future AD/ADRD).
Funding Opportunity PAR-24-139 from the NIH Guide for Grants and Contracts. To support outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical, clinical, behavioral and social sciences, over the transition from predoctoral to postdoctoral research training.. This phased award program will facilitate completion of graduate PhD or dual degree clinician scientist programs (F99) and progression to mentored postdoctoral positions in dental, oral and craniofacial research (K00).
Notice NOT-MH-24-225 from the NIH Guide for Grants and Contracts
Notice NOT-NS-24-068 from the NIH Guide for Grants and Contracts
Notice NOT-MD-24-012 from the NIH Guide for Grants and Contracts
Notice NOT-HD-24-022 from the NIH Guide for Grants and Contracts
Notice NOT-HD-24-021 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-099 from the NIH Guide for Grants and Contracts
Notice NOT-HL-24-012 from the NIH Guide for Grants and Contracts